Mehdi Farhoudi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mehdi Farhoudi has a total of 867 co-authors. Here are the top co-authors by number of shared publications:
- Saeed Sadigh-Eteghad
Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran
22 shared publications - Elyar Sadeghi-Hokmabadi
Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
18 shared publications - Javad Mahmoudi
Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
11 shared publications Mahnaz Talebi
Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
10 shared publications- Behzad Baradaran
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
7 shared publications Homayoun Sadeghi-Bazargani
Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
7 shared publications
Latest Publications
- Open Access
Increased stroke risk in patients with Alopecia Areata: A systematic review and meta-analysis
- Open Access
- 28 May 2026
- Published by Elsevier in SSRN Electronic Journal
Intravenous Thrombolysis for Acute Ischemic Stroke Across the Middle East and North Africa (2021–2023): Results from the SITS-MENA Registry
Background: Intravenous thrombolysis (IVT) for acute ischemic stroke in the Middle-East and North African (MENA) countries has increased in the last decade, but long-term outcomes and quality of care are less well studied. Methods: This was a prospective observational study to examine 3-month outcomes of IVT-treated patients in MENA stroke units using the SITS Registry. Findings: There were 2768 patients in MENA and 7163 patents in non-MENA treated with IVT and registered in SITS between August 2021 and September 2023. Compared to non-MENA, MENA patients were younger (65 vs 72 years-old), had higher NIH Stroke Scale scores at baseline (11 vs 9) and shorter door-to-needle times (30 vs 54 min). The most common risk factors in MENA were hypertension (64.9 vs 69.8 %) and diabetes (30.8 vs 20.1%). Functional independence at 3 months was similar (56.6% vs 57.7%); however, mortality at 7 and 30 days was significantly higher in MENA (8.3% vs 5.3% and 20.7 vs 14.5%). Symptomatic intracranial hemorrhage rates were low in both groups (<1.2% per SITS-MOST). Early mortality rates related to stroke were comparable (56.7 vs 59.2%) but early deaths caused by myocardial infarction, pneumonia, pulmonary embolism and sepsis were more frequent in MENA (14.2 vs 4.6%, 6.7 vs 4.6%, 1.5 vs 0.4% and 3 vs 1.8%). Interpretation: The overall mortality of IVT-treated patients was increased in MENA at 7 and 90 days post-stroke. Differences in risk factors at baseline may account for mortality but the treatment of medical complications in MENA stroke units warrants further study.
- 28 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessIntravenous Thrombolysis for Acute Ischemic Stroke Across the Middle East and North Africa (2021–2023): Results from the SITS-MENA Registry
Background: Intravenous thrombolysis (IVT) for acute ischemic stroke in the Middle-East and North African (MENA) countries has increased in the last decade, but long-term outcomes and quality of care are less well studied. Methods: This was a prospective observational study to examine 3-month outcomes of IVT-treated patients in MENA stroke units using the SITS Registry. Findings: There were 2768 patients in MENA and 7163 patents in non-MENA treated with IVT and registered in SITS between August 2021 and September 2023. Compared to non-MENA, MENA patients were younger (65 vs 72 years-old), had higher NIH Stroke Scale scores at baseline (11 vs 9) and shorter door-to-needle times (30 vs 54 min). The most common risk factors in MENA were hypertension (64.9 vs 69.8 %) and diabetes (30.8 vs 20.1%). Functional independence at 3 months was similar (56.6% vs 57.7%); however, mortality at 7 and 30 days was significantly higher in MENA (8.3% vs 5.3% and 20.7 vs 14.5%). Symptomatic intracranial hemorrhage rates were low in both groups (<1.2% per SITS-MOST). Early mortality rates related to stroke were comparable (56.7 vs 59.2%) but early deaths caused by myocardial infarction, pneumonia, pulmonary embolism and sepsis were more frequent in MENA (14.2 vs 4.6%, 6.7 vs 4.6%, 1.5 vs 0.4% and 3 vs 1.8%). Interpretation: The overall mortality of IVT-treated patients was increased in MENA at 7 and 90 days post-stroke. Differences in risk factors at baseline may account for mortality but the treatment of medical complications in MENA stroke units warrants further study.
- Open Access
- 1 April 2026
- Published by InkVista Publishing House
- Vol. 12 (2) , 127-133
Air Pollution and Risk of Stroke: A Multi-Year Analysis of PM2.5 and Other Pollutants in Tabriz, Iran
- 1 April 2026
- Published by InkVista Publishing House
- Vol. 12 (2) , 127-133
Open AccessAir Pollution and Risk of Stroke: A Multi-Year Analysis of PM2.5 and Other Pollutants in Tabriz, Iran
- Open Access
- 26 February 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Circulating IncRNAs and Their Association With Ischemic Stroke Severity and Prognosis: A Systematic Review and Meta‐Analysis
Background and Aims: Stroke is the most significant contributor to morbidity worldwide. Prognostication in stroke patients could lead to better planning and care and, subsequently, better outcomes. Recently, lncRNAs have become a hot topic as biomarkers of different diseases. This study aims to systematically assess the utility of lncRNAs in stroke prognosis. Methods: We systematically searched for relevant articles in Medline (via PubMed interface), EMBASE, Web of Science, and Scopus databases from their inception to April 6th, 2024. Inclusions were limited to original peer‐reviewed papers in English that assessed the correlation between circulating lncRNA levels and stroke severity (all subtypes) and/or prognosis. Completeness of the report was evaluated with the “Strengthening the Reporting of Observational Studies in Epidemiology” (STROBE) checklist, and quality assessment was performed with “Quality in Prognosis Studies” (QUIPS) and “Newcastle Ottawa scale” (NOS) checklists. Results: Of the 1134 unique citations gathered, 60 were assessed in full text for inclusion, and 30 were included in the final analysis. Although our search strategy covered all stroke subtypes, no eligible studies were found for hemorrhagic stroke; thus, only ischemic stroke and TIA populations were included. We included 30 studies in our analysis, which included 3719 patients and 4433 data points. The pooled correlation between circulating lncRNAs and NIHSS was 0.52 (CI95%:0.43–0.60), and circulating lncRNAs and the modified Rankin Scale was 0.49 (CI95%:0.26–0.67). The pooled odds ratio for the mortality prediction was 1.55 (CI 95%:1.26–1.92). Quality assessment of included studies showed that most of the studies had a low risk of bias and high completeness of report. Conclusion: LncRNAs show modest to moderate predictive accuracy in assessing stroke severity and prognosis. While these findings are encouraging, Further research is needed to solidify their utility in stroke care.
- 26 February 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Open AccessCirculating IncRNAs and Their Association With Ischemic Stroke Severity and Prognosis: A Systematic Review and Meta‐Analysis
Background and Aims: Stroke is the most significant contributor to morbidity worldwide. Prognostication in stroke patients could lead to better planning and care and, subsequently, better outcomes. Recently, lncRNAs have become a hot topic as biomarkers of different diseases. This study aims to systematically assess the utility of lncRNAs in stroke prognosis. Methods: We systematically searched for relevant articles in Medline (via PubMed interface), EMBASE, Web of Science, and Scopus databases from their inception to April 6th, 2024. Inclusions were limited to original peer‐reviewed papers in English that assessed the correlation between circulating lncRNA levels and stroke severity (all subtypes) and/or prognosis. Completeness of the report was evaluated with the “Strengthening the Reporting of Observational Studies in Epidemiology” (STROBE) checklist, and quality assessment was performed with “Quality in Prognosis Studies” (QUIPS) and “Newcastle Ottawa scale” (NOS) checklists. Results: Of the 1134 unique citations gathered, 60 were assessed in full text for inclusion, and 30 were included in the final analysis. Although our search strategy covered all stroke subtypes, no eligible studies were found for hemorrhagic stroke; thus, only ischemic stroke and TIA populations were included. We included 30 studies in our analysis, which included 3719 patients and 4433 data points. The pooled correlation between circulating lncRNAs and NIHSS was 0.52 (CI95%:0.43–0.60), and circulating lncRNAs and the modified Rankin Scale was 0.49 (CI95%:0.26–0.67). The pooled odds ratio for the mortality prediction was 1.55 (CI 95%:1.26–1.92). Quality assessment of included studies showed that most of the studies had a low risk of bias and high completeness of report. Conclusion: LncRNAs show modest to moderate predictive accuracy in assessing stroke severity and prognosis. While these findings are encouraging, Further research is needed to solidify their utility in stroke care.
- 25 November 2025
- Published by Elsevier in Journal of Vascular Nursing
- Vol. 44 (1) , 38-42
Dose-dependent neurotoxic impact of cigarette smoking on post-stroke survival
- 25 November 2025
- Published by Elsevier in Journal of Vascular Nursing
- Vol. 44 (1) , 38-42
Dose-dependent neurotoxic impact of cigarette smoking on post-stroke survival
- 10 September 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (7) , 264
4-aminopyridine exerts anxiolytic and pro-cognitive effects in mice model of medial prefrontal cortex ischemia
Brain ischemia is a major global cause of disability, frequently leading to psychoneurological issues. This study investigates the effects of 4-aminopyridine (4-AP) on anxiety, cognitive impairment, and potential underlying mechanisms in a mouse model of medial prefrontal cortex (mPFC) ischemia. Mice with mPFC ischemia were treated with normal saline (NS) or different doses of 4-AP (250, 500, and 1000 µg/kg) for 14 consecutive days. The open field test, elevated plus maze, Barnes maze, and novel object recognition test were used to perform a series of behavioral assessments to evaluate anxiety as well as spatial and episodic memory. Serum corticosterone levels and changes in oxidative stress markers (MDA, SOD, GPx, and TAC) were measured by ELISA. Inflammatory and apoptotic markers (p-P38, NF-κB, IL-1β, TNF-α, p-PI3K, p-AKT, Caspase-3, BAX, and BCL2) were analyzed via western blotting. Results showed that mPFC ischemia induced anxiety-like behavior and disrupted both recognition and spatial memory at the behavioral level. Additionally, ischemia increased serum corticosterone levels, elevated oxidative stress, and upregulated inflammatory and apoptotic markers. However, 4-AP at the highest dose significantly mitigated these behavioral and molecular deficits. These findings suggest that 4-AP alleviates anxiety-like behavior and cognitive impairment associated with mPFC ischemia, possibly through modulation of corticosterone, oxidative stress, inflammation, and apoptotic signaling pathways.
- 10 September 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (7) , 264
4-aminopyridine exerts anxiolytic and pro-cognitive effects in mice model of medial prefrontal cortex ischemia
Brain ischemia is a major global cause of disability, frequently leading to psychoneurological issues. This study investigates the effects of 4-aminopyridine (4-AP) on anxiety, cognitive impairment, and potential underlying mechanisms in a mouse model of medial prefrontal cortex (mPFC) ischemia. Mice with mPFC ischemia were treated with normal saline (NS) or different doses of 4-AP (250, 500, and 1000 µg/kg) for 14 consecutive days. The open field test, elevated plus maze, Barnes maze, and novel object recognition test were used to perform a series of behavioral assessments to evaluate anxiety as well as spatial and episodic memory. Serum corticosterone levels and changes in oxidative stress markers (MDA, SOD, GPx, and TAC) were measured by ELISA. Inflammatory and apoptotic markers (p-P38, NF-κB, IL-1β, TNF-α, p-PI3K, p-AKT, Caspase-3, BAX, and BCL2) were analyzed via western blotting. Results showed that mPFC ischemia induced anxiety-like behavior and disrupted both recognition and spatial memory at the behavioral level. Additionally, ischemia increased serum corticosterone levels, elevated oxidative stress, and upregulated inflammatory and apoptotic markers. However, 4-AP at the highest dose significantly mitigated these behavioral and molecular deficits. These findings suggest that 4-AP alleviates anxiety-like behavior and cognitive impairment associated with mPFC ischemia, possibly through modulation of corticosterone, oxidative stress, inflammation, and apoptotic signaling pathways.
- Open Access
- 1 July 2025
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 16 (4) , 805-818
Intranasal Autologous Conditioned Serum Attenuates Memory Impairment After mPFC Ischemia in Mice
Introduction: Globally, stroke ranks as the second most prevalent cause of death, contributing significantly to worldwide mortality burdens, imposing a significant economic and emotional challenge on societies. This study was designed to investigate the effect of autologous conditioned serum (ACS) on memory and associated molecular factors in a mouse model of photothrombotic ...
- 1 July 2025
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 16 (4) , 805-818
Open AccessIntranasal Autologous Conditioned Serum Attenuates Memory Impairment After mPFC Ischemia in Mice
Introduction: Globally, stroke ranks as the second most prevalent cause of death, contributing significantly to worldwide mortality burdens, imposing a significant economic and emotional challenge on societies. This study was designed to investigate the effect of autologous conditioned serum (ACS) on memory and associated molecular factors in a mouse model of photothrombotic ...
- Open Access
Post-stroke Urinary Tract Infections and Their Outcome: A Clinico-microbiological and Epidemiological Analysis based on A Stroke Registry
Background: Urinary tract infections (UTIs) are common among hospitalized stroke patients, leading to increased hospital stays and patient discomfort. While it’s known that post-stroke infections generally worsen outcomes, specific factors contributing to UTIs after stroke remain unclear. Methods: This study aimed to investigate the incidence of post-stroke UTI (PSUTI) in patients admitted to the Hospitals from September 2020 to June 2021. The study included patients with a suspected diagnosis of stroke at the time of initial visit by a specialist. The final diagnosis was approved by an experienced neurologist and radiologist according to their brain CT scan. Data was collected from patients’ files, including demographics, comorbidities, drug history, smoking history, admission unit, clinical manifestations, systolic and diastolic blood pressure, type of stroke, etiology, laboratory findings, admission unit, in-hospital stay duration, therapies, use of NG tubes, urinary catheters, CV lines, brain drain, intratracheal tube, chest tube, dialysis catheter, and their durations. Results: A study involving 612 patients found that PSUTI-positive patients had worse conditions at admission, with ischemic stroke being more common. They had longer stays in the ward or ICU, and were more likely to have a death outcome. The most common pathogen was Escherichia coli, followed by Staphylococcus epidermidis, Enterococcus spp, and Pseudomonas aeruginosa. In-hospital complications were more prevalent in PSUTI-positive patients, except for hydrocephalus and pulmonary embolism. Positive history of diabetes, falling symptoms, urinary catheter, and intubation were independent risk factors for post-stroke UTI. Conclusion: The study highlights the impact of urinary tract infections (UTIs) on stroke outcomes, revealing severe clinical profiles, comorbidities, longer hospital stays, and increased invasive interventions. Key risk factors like diabetes and urinary catheter use highlight the need for vigilant monitoring and tailored management strategies.
Open AccessPost-stroke Urinary Tract Infections and Their Outcome: A Clinico-microbiological and Epidemiological Analysis based on A Stroke Registry
Background: Urinary tract infections (UTIs) are common among hospitalized stroke patients, leading to increased hospital stays and patient discomfort. While it’s known that post-stroke infections generally worsen outcomes, specific factors contributing to UTIs after stroke remain unclear. Methods: This study aimed to investigate the incidence of post-stroke UTI (PSUTI) in patients admitted to the Hospitals from September 2020 to June 2021. The study included patients with a suspected diagnosis of stroke at the time of initial visit by a specialist. The final diagnosis was approved by an experienced neurologist and radiologist according to their brain CT scan. Data was collected from patients’ files, including demographics, comorbidities, drug history, smoking history, admission unit, clinical manifestations, systolic and diastolic blood pressure, type of stroke, etiology, laboratory findings, admission unit, in-hospital stay duration, therapies, use of NG tubes, urinary catheters, CV lines, brain drain, intratracheal tube, chest tube, dialysis catheter, and their durations. Results: A study involving 612 patients found that PSUTI-positive patients had worse conditions at admission, with ischemic stroke being more common. They had longer stays in the ward or ICU, and were more likely to have a death outcome. The most common pathogen was Escherichia coli, followed by Staphylococcus epidermidis, Enterococcus spp, and Pseudomonas aeruginosa. In-hospital complications were more prevalent in PSUTI-positive patients, except for hydrocephalus and pulmonary embolism. Positive history of diabetes, falling symptoms, urinary catheter, and intubation were independent risk factors for post-stroke UTI. Conclusion: The study highlights the impact of urinary tract infections (UTIs) on stroke outcomes, revealing severe clinical profiles, comorbidities, longer hospital stays, and increased invasive interventions. Key risk factors like diabetes and urinary catheter use highlight the need for vigilant monitoring and tailored management strategies.
- Open Access
- 3 February 2025
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences
- Vol. 47 (1) , 17-28
Factors affecting the survival of stroke patients in the last eight years using parametric and non-parametric models: A study in the northwest of Iran
Background. The aim of this study was to evaluate factors affecting the survival of 5,430 stroke patients in the northwest of Iran using parametric and non-parametric models of survival analysis. Methods. This longitudinal school-based study was retrospectively conducted using the registered data of 5,430 stroke patients in Tabriz. The Akaike criterion and Cox-Snell residual diagram were used to evaluate the parametric models, and the Kaplan-Meyer curve was employed for assessing the non-parametric model. Analyses were performed using STATA17. Results. The findings demonstrated that different factors were associated with an increased risk of death from stroke, including the age group of 65 and older (proportional hazard [PH]= 1.75 and P<0.001), snoring (PH=1.34 and P= 0.005), addiction (PH= 1.87 and P= 0.007), smoking (PH= 5.94 and P< 0.001), and hookah use (PH = 1.81 and P= 0.005). The other related factors were diabetes (PH= 1.46 and P= 0.001), aspiration pneumonia (PH = 2.09 and P < 0.001), atrial fibrillation (PH= 1.59 and P= 0.002), systolic hypertension (PH= 3.15 and P< 0.001), and high triglyceride (PH = 1.33 and P= 0.012). Considering the frailty, the fitness of the Weibull model was better than that of the other models. Conclusion. According to the findings, snoring and having aspiration pneumonia were two important risk factors related to the survival of stroke patients. It is also recommended that the parametric models of survival analysis be used if the relevant assumptions are established. Practical Implications. The risk factors determined in the present study can be utilized in determining relevant interventions. It is recommended that identification programs such as screening and treatment of patients be implemented in this respect.
- 3 February 2025
- Published by Maad Rayan Publishing Company in Medical Journal of Tabriz University of Medical Sciences
- Vol. 47 (1) , 17-28
Open AccessFactors affecting the survival of stroke patients in the last eight years using parametric and non-parametric models: A study in the northwest of Iran
Background. The aim of this study was to evaluate factors affecting the survival of 5,430 stroke patients in the northwest of Iran using parametric and non-parametric models of survival analysis. Methods. This longitudinal school-based study was retrospectively conducted using the registered data of 5,430 stroke patients in Tabriz. The Akaike criterion and Cox-Snell residual diagram were used to evaluate the parametric models, and the Kaplan-Meyer curve was employed for assessing the non-parametric model. Analyses were performed using STATA17. Results. The findings demonstrated that different factors were associated with an increased risk of death from stroke, including the age group of 65 and older (proportional hazard [PH]= 1.75 and P<0.001), snoring (PH=1.34 and P= 0.005), addiction (PH= 1.87 and P= 0.007), smoking (PH= 5.94 and P< 0.001), and hookah use (PH = 1.81 and P= 0.005). The other related factors were diabetes (PH= 1.46 and P= 0.001), aspiration pneumonia (PH = 2.09 and P < 0.001), atrial fibrillation (PH= 1.59 and P= 0.002), systolic hypertension (PH= 3.15 and P< 0.001), and high triglyceride (PH = 1.33 and P= 0.012). Considering the frailty, the fitness of the Weibull model was better than that of the other models. Conclusion. According to the findings, snoring and having aspiration pneumonia were two important risk factors related to the survival of stroke patients. It is also recommended that the parametric models of survival analysis be used if the relevant assumptions are established. Practical Implications. The risk factors determined in the present study can be utilized in determining relevant interventions. It is recommended that identification programs such as screening and treatment of patients be implemented in this respect.
- Open Access
- 1 January 2025
- Published by Wiley in Stroke Research and Treatment
- Vol. 2025 (1)
Transcranial Direct Current Stimulation and Mindfulness for Cognitive and Mood Recovery in Stroke Survivors: A Pilot Randomized Controlled Study
Background: Cognitive impairments and depression are common after stroke. Noninvasive treatments like transcranial direct current stimulation (tDCS) and mindfulness‐based interventions have shown potential for improving these outcomes, though their effects on stroke survivors remain unclear. This study is aimed at evaluating the efficacy of mindfulness and tDCS in enhancing cognitive function and alleviating depression in stroke survivors. Methods: This randomized controlled trial, conducted from July 2021 to July 2022, included 30 stroke survivors divided into three groups: mindfulness ( n = 5), tDCS ( n = 14), and control ( n = 11). Cognitive function was measured using Addenbrooke’s Cognitive Examination‐III (ACE‐III), and depression was assessed using the Beck Depression Inventory‐II (BDI‐II) before and after interventions. The tDCS group received 10 sessions of anodal stimulation, and the mindfulness group underwent eight weekly sessions of mindfulness‐based stress reduction. Data were analyzed using paired t ‐tests for within‐group comparisons and ANOVA for between‐group differences. Results: The tDCS group showed significant improvement in cognitive function, with ACE‐III scores increasing by 9.14 ± 8.24 points ( p = 0.02). Fluency and orientation scores also improved significantly in this group ( p < 0.001 and p = 0.01, respectively). No significant cognitive changes were observed in the mindfulness group. Depression scores (BDI‐II) did not change significantly in any group. Conclusions: tDCS significantly improved cognitive performance, particularly in fluency and orientation, while mindfulness showed no significant cognitive or depression‐related effects. Future studies should explore the long‐term impact of these interventions in stroke rehabilitation. Trial Registration: ClinicalTrials.gov identifier: IRCT20090716002195N3
- 1 January 2025
- Published by Wiley in Stroke Research and Treatment
- Vol. 2025 (1)
Open AccessTranscranial Direct Current Stimulation and Mindfulness for Cognitive and Mood Recovery in Stroke Survivors: A Pilot Randomized Controlled Study
Background: Cognitive impairments and depression are common after stroke. Noninvasive treatments like transcranial direct current stimulation (tDCS) and mindfulness‐based interventions have shown potential for improving these outcomes, though their effects on stroke survivors remain unclear. This study is aimed at evaluating the efficacy of mindfulness and tDCS in enhancing cognitive function and alleviating depression in stroke survivors. Methods: This randomized controlled trial, conducted from July 2021 to July 2022, included 30 stroke survivors divided into three groups: mindfulness ( n = 5), tDCS ( n = 14), and control ( n = 11). Cognitive function was measured using Addenbrooke’s Cognitive Examination‐III (ACE‐III), and depression was assessed using the Beck Depression Inventory‐II (BDI‐II) before and after interventions. The tDCS group received 10 sessions of anodal stimulation, and the mindfulness group underwent eight weekly sessions of mindfulness‐based stress reduction. Data were analyzed using paired t ‐tests for within‐group comparisons and ANOVA for between‐group differences. Results: The tDCS group showed significant improvement in cognitive function, with ACE‐III scores increasing by 9.14 ± 8.24 points ( p = 0.02). Fluency and orientation scores also improved significantly in this group ( p < 0.001 and p = 0.01, respectively). No significant cognitive changes were observed in the mindfulness group. Depression scores (BDI‐II) did not change significantly in any group. Conclusions: tDCS significantly improved cognitive performance, particularly in fluency and orientation, while mindfulness showed no significant cognitive or depression‐related effects. Future studies should explore the long‐term impact of these interventions in stroke rehabilitation. Trial Registration: ClinicalTrials.gov identifier: IRCT20090716002195N3